Initial ribociclib plus endocrine therapy for HR+/HER2- advanced breast cancer in pre- and postmenopausal Chinese women: Primary results from a phase 2 randomized study.

Subjects

Subjects :

Humans
Female
Middle Aged
Adult
China
Aged
Receptors, Progesterone metabolism
Premenopause
Progression-Free Survival
Goserelin administration & dosage
Goserelin therapeutic use
Aromatase Inhibitors administration & dosage
Aromatase Inhibitors therapeutic use
East Asian People
Aminopyridines administration & dosage
Aminopyridines therapeutic use
Aminopyridines adverse effects
Breast Neoplasms drug therapy
Breast Neoplasms mortality
Breast Neoplasms pathology
Breast Neoplasms metabolism
Purines administration & dosage
Purines adverse effects
Postmenopause
Receptor, ErbB-2 metabolism
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Antineoplastic Combined Chemotherapy Protocols adverse effects
Receptors, Estrogen metabolism
Letrozole administration & dosage
Letrozole therapeutic use

Details

Language :

English

ISSN :

2045-7634

Volume :

13

Issue :

15

Database :

MEDLINE

Journal :

Cancer medicine

Publication Type :

Academic Journal

Accession number :

39136200

Full Text :

https://doi.org/10.1002/cam4.7408